Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-Induced Nausea and Vomiting (CINV)”

98 trials

Showing 20 of 98 results

Early research (Phase 1)Study completedNCT01111851
What this trial is testing

Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)Study completedNCT05319860
What this trial is testing

Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
University of Miami 100
Post-approval studies (Phase 4)Study completedNCT04817189
What this trial is testing

Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Helsinn Healthcare SA 414
Testing effectiveness (Phase 2)Ended earlyNCT03008213
What this trial is testing

Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV

Who this might be right for
Chemotherapy Induced Nausea Vomiting
Joseph Ma 4
Large-scale testing (Phase 3)Study completedNCT00619359
What this trial is testing

Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 2,322
Large-scale testing (Phase 3)Study completedNCT00880191
What this trial is testing

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

Who this might be right for
Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 430
Post-approval studies (Phase 4)UnknownNCT02576327
What this trial is testing

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Vomiting
Jun Zhu 130
Not applicableNot Yet RecruitingNCT06950632
What this trial is testing

This Study Will Investigate the Effectiveness of Peppermint Oil Inhalation in Reducing the Intensity and Frequency of Acute Nausea and Vomiting Among Cancer Patients Undergoing Chemotherapy. Chemotherapy-induced Nausea and Vomiting (CINV) Are Among the Most Distressing Side Effects Experienced by pa

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
University of Health Sciences Lahore 106
Early research (Phase 1)Not Yet RecruitingNCT07817004
What this trial is testing

QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administration

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Qilu Pharmaceutical (Hainan) Co., Ltd. 42
Testing effectiveness (Phase 2)Study completedNCT00787566
What this trial is testing

Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Shin Nippon Biomedical Laboratories, Ltd. 68
Not applicableLooking for participantsNCT06756022
What this trial is testing

Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
Anhui Provincial Children's Hospital 500
Large-scale testing (Phase 3)Study completedNCT01594749
What this trial is testing

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 1,015
Testing effectiveness (Phase 2)Study completedNCT00394966
What this trial is testing

A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)

Who this might be right for
NauseaVomiting
Schering-Plough 450
Large-scale testing (Phase 3)Study completedNCT01499849
What this trial is testing

Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Tesaro, Inc. 532
Large-scale testing (Phase 3)Study completedNCT06331520
What this trial is testing

NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens

Who this might be right for
Chemotherapy-induced Nausea and VomitingHighly Emetogenic Chemotherapy
Fudan University 644
Large-scale testing (Phase 3)UnknownNCT04201769
What this trial is testing

Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Consorzio Oncotech 261
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06593782
What this trial is testing

Evaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Nausea and Vomiting, Chemotherapy-Induced
First Affiliated Hospital of Wenzhou Medical University 180
Testing effectiveness (Phase 2)Study completedNCT00104403
What this trial is testing

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

Who this might be right for
Nausea and Vomiting, Chemotherapy-InducedChemotherapy-Induced Nausea and Vomiting
GlaxoSmithKline 722
Post-approval studies (Phase 4)Study completedNCT04054193
What this trial is testing

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Merck Sharp & Dohme LLC 103
Large-scale testing (Phase 3)Study completedNCT01442376
What this trial is testing

Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Helsinn Healthcare SA 502
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation